Leveraging Prior Knowledge in the Development of Human Gene Therapy Products Incorporating Genome Editing; Draft Guidance for Industry
FDA-2026-D-1257-0002Other
Comments
2
Last activity Jul 16, 2026
Deadline
29 days
Closes Sep 2, 2026
Net supportiSupport minus oppose · campaigns included
—
Document
Details
The document's own metadata, straight from the source system.
- Title
- Leveraging Prior Knowledge in the Development of Human Gene Therapy Products Incorporating Genome Editing; Draft Guidance for Industry
- Posted
- Jun 3, 2026
- Comment period
- Jun 3, 2026 – Sep 2, 2026
- Topics
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Include campaigns
Analyzed 0 of 2 comments
0%· analysis in progress
Stance breakdown
—
Net support
Not yet analyzed2
Who commented
Breakdown by commenter type.
Not yet analyzed
2
Comments over time
Weekly arrivals, stacked by stance.
Posted Jun 3, 2026Deadline Sep 2, 2026
Jun 8Jul 13
Support0Oppose0Other0
Issues raised
The docket's canonical issues. Select one to browse its comments.
Issues are identified as comment analysis progresses — nothing tagged on this document yet.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.